Skip to content

EFFECT OF PAROXETINE AND FLUOXETINE ON GUM HEALTH IN PATIENTS OF DEPRESSION AND PYORRHEA.

EVALUATION OF THE EFFECT OF PAROXETINE AND FLUOXETINE ON PERIODONTAL PARAMETERS IN THE PATIENTS WITH DEPRESSION AND PERIODONTITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/037995
Enrollment
332
Registered
2021-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F320- Major depressive disorder, singleepisode, mild

Interventions

None listed

Sponsors

DR SINAM SUBHASCHANDRA SINGH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with depression and periodontitis. 2. Patient should have minimum 20 teeth other than third molars. Periodontitis criteria Stage 1 and 2 generalized Periodontitis patients as per the 2017 periodontitis classification Depression criteria Diagnosis of depression will be made using ICD-10 criteria, In typical depressive episodes of all three varieties a. (mild (F32.0), b. moderate (F32.1), and c. severe (F32.2 and F32.3)

Exclusion criteria

Exclusion criteria: 1. History of systemic disease or condition that is reported to be associated with periodontal disease, including diabetes mellitus, osteoporosis, rheumatoid arthritis, chronic renal failure, cardiovascular disease, and pregnancy. 2. Treatment with the following drugs in the previous 3 months: antibiotics, anti-inflammatories, steroids, immunosuppressants, lipid-lowering drugs, anticoagulants, bisphosphonates, and host modulatory drugs. 3. Patients on anyantidepressant medication besides Paroxetine andFluoxetine. 4. Patients who have undergone periodontal treatment (non-surgical or surgical) 6 months prior to the study

Design outcomes

Primary

MeasureTime frame
The present study expected to shows effect of paroxetine and fluoxetine on periodontal parameters in the patients with depressions and periodontitis.Timepoint: 3 months

Secondary

MeasureTime frame
the results of the study may bring out an additional therapeutic advantage on the inflammatory periodontal diseases of the drugs under comparison.Timepoint: 12 months

Countries

India

Contacts

Public ContactDR SACHIDANANDA CHUNGKHAM

Regional institute of medical sciences (RIMS)

leninrk@yahoo.com9862088736

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026